Efficacy and Safety of Allogeneic Mesenchymal Stromal Cells Versus Lokivetmab in Mild-To-Moderate Canine Atopic Dermatitis A Single-Blind Randomised Study.

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Veterinary dermatology in 2026 evaluated efficacy and Safety of Allogeneic Mesenchymal Stromal Cells Versus Lokivetmab in Mild-To-Moderate Canine Atopic Dermatitis: A Single-Blind Randomised Study..

Key Findings

Canine atopic dermatitis (cAD) is a chronic allergic inflammatory skin disease that requires multimodal management. Allogeneic mesenchymal stromal cells (MSCs) have emerged as a potential therapeutic option. To evaluate the efficacy and safety of an investigational allogeneic adipose-derived MSC product (PK/CM-1) in dogs with cAD. Dogs with mild-to-moderate cAD were enrolled in a single-blind, randomised study and allocated in a 2:1 ratio either to an experimental group (receiving a single intravenous dose of PK/CM-1) or a control group (receiving three monthly subcutaneous doses of lokivetmab). Clinical outcomes were assessed using the...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for canine patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

• Read the full article here: https://pubmed.ncbi.nlm.nih.gov/42908490/